<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="ene70092" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Neurol</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Neurol</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1468-1331</journal-id><journal-id journal-id-type="publisher-id">ENE</journal-id><journal-title-group><journal-title>European Journal of Neurology</journal-title></journal-title-group><issn pub-type="ppub">1351-5101</issn><issn pub-type="epub">1468-1331</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40008680</article-id><article-id pub-id-type="pmc">PMC11863069</article-id><article-id pub-id-type="doi">10.1111/ene.70092</article-id><article-id pub-id-type="publisher-id">ENE70092</article-id><article-id pub-id-type="other">EJoN-24-2120.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Sex&#x02010;Related Differences in Outcomes of Endovascular Treatment in Large Vessel Occlusion Stroke&#x02014;Analyses From the German Stroke Registry&#x02010;Endovascular Treatment</article-title></title-group><contrib-group><contrib id="ene70092-cr-0001" contrib-type="author"><name><surname>Single</surname><given-names>Constanze</given-names></name><xref rid="ene70092-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="ene70092-cr-0002" contrib-type="author"><name><surname>Mengel</surname><given-names>Annerose</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2399-3020</contrib-id><xref rid="ene70092-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ene70092-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ene70092-cr-0003" contrib-type="author"><name><surname>Laichinger</surname><given-names>Kornelia</given-names></name><xref rid="ene70092-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ene70092-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ene70092-cr-0004" contrib-type="author"><name><surname>Sartor&#x02010;Pfeiffer</surname><given-names>Jennifer</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0275-1134</contrib-id><xref rid="ene70092-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ene70092-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ene70092-cr-0005" contrib-type="author"><name><surname>Selo</surname><given-names>Nadja</given-names></name><xref rid="ene70092-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="ene70092-cr-0006" contrib-type="author"><name><surname>Hennersdorf</surname><given-names>Florian</given-names></name><xref rid="ene70092-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="ene70092-cr-0007" contrib-type="author"><name><surname>Bender</surname><given-names>Benjamin</given-names></name><xref rid="ene70092-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="ene70092-cr-0008" contrib-type="author"><name><surname>Deb&#x02010;Chatterji</surname><given-names>Milani</given-names></name><xref rid="ene70092-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="ene70092-cr-0009" contrib-type="author"><name><surname>Thomalla</surname><given-names>G&#x000f6;tz</given-names></name><xref rid="ene70092-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="ene70092-cr-0010" contrib-type="author"><name><surname>Mbroh</surname><given-names>Joshua</given-names></name><xref rid="ene70092-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ene70092-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ene70092-cr-0011" contrib-type="author"><name><surname>Poli</surname><given-names>Sven</given-names></name><xref rid="ene70092-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ene70092-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ene70092-cr-0012" contrib-type="author"><name><surname>Ziemann</surname><given-names>Ulf</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8372-3615</contrib-id><xref rid="ene70092-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ene70092-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ene70092-cr-0013" contrib-type="author"><name><surname>Ernemann</surname><given-names>Ulrike</given-names></name><xref rid="ene70092-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="ene70092-cr-0014" contrib-type="author" corresp="yes"><name><surname>Feil</surname><given-names>Katharina</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4566-712X</contrib-id><xref rid="ene70092-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>katharina.feil@uni-tuebingen.de</email></address></contrib><contrib id="ene70092-cr-0015" contrib-type="author"><collab collab-type="authors">German Stroke Registry&#x02014;Endovascular Treatment (GSR)</collab></contrib></contrib-group><aff id="ene70092-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Neurology &#x00026; Stroke</named-content>
<institution>Eberhard&#x02010;Karls University</institution>
<city>T&#x000fc;bingen</city>
<country country="DE">Germany</country>
</aff><aff id="ene70092-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Hertie Institute for Clinical Brain Research</named-content>
<institution>Eberhard&#x02010;Karls University</institution>
<city>T&#x000fc;bingen</city>
<country country="DE">Germany</country>
</aff><aff id="ene70092-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Neuroradiology</named-content>
<institution>Eberhard&#x02010;Karls University</institution>
<city>T&#x000fc;bingen</city>
<country country="DE">Germany</country>
</aff><aff id="ene70092-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<institution>University Medical Centre Schleswig&#x02010;Holstein</institution>
<city>Kiel</city>
<country country="DE">Germany</country>
</aff><aff id="ene70092-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<institution>University Medical Center Hamburg&#x02010;Eppendorf</institution>
<city>Hamburg</city>
<country country="DE">Germany</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold>
<break/>
Katharina Feil (<email>katharina.feil@uni-tuebingen.de</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>26</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2025</year></pub-date><volume>32</volume><issue seq="60">3</issue><issue-id pub-id-type="doi">10.1111/ene.v32.3</issue-id><elocation-id>e70092</elocation-id><history>
<date date-type="rev-recd"><day>07</day><month>1</month><year>2025</year></date>
<date date-type="received"><day>05</day><month>10</month><year>2024</year></date>
<date date-type="accepted"><day>10</day><month>2</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 European Academy of Neurology--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">European Journal of Neurology</italic> published by John Wiley &#x00026; Sons Ltd on behalf of European Academy of Neurology.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:ENE-32-e70092.pdf"/><abstract><title>ABSTRACT</title><sec id="ene70092-sec-0001"><title>Background</title><p>Sex&#x02010;related differences in acute ischemic stroke may affect outcomes, yet evidence remains inconsistent. This large&#x02010;scale study investigated sex&#x02010;related differences in clinical presentation, peri&#x02010;interventional parameters, and outcomes after endovascular thrombectomy (EVT) for large vessel occlusion (LVO) using data from the German Stroke Registry&#x02014;Endovascular Treatment (GSR&#x02010;ET).</p></sec><sec id="ene70092-sec-0002"><title>Methods</title><p>We analyzed 11.896 EVT patients (52.2% female) from the GSR&#x02010;ET (June 2015&#x02013;December 2021) comparing clinical characteristics, treatment details, and outcomes by sex. Two propensity score matchings (PSM) were applied: (1) logistic regression model with a caliper width of 0.1 on age, pre&#x02010;stroke modified Rankin Scale (pmRS), and National Institutes of Health Stroke Scale at admission, and (2) 1:1 nearest neighbor matching with a caliper of 0.01. Primary outcomes were good (mRS 0&#x02013;2) and excellent (mRS 0&#x02013;1) outcomes at discharge and 90&#x02010;day follow&#x02010;up.</p></sec><sec id="ene70092-sec-0003"><title>Results</title><p>Women were older (76.3&#x02009;&#x000b1;&#x02009;12.7 vs. 70.2&#x02009;&#x000b1;&#x02009;12.9&#x02009;years, <italic toggle="no">p</italic>&#x02009;&#x0003c;&#x02009;0.001) and had higher pre&#x02010;stroke disability (median pmRS 0 (0, 2) vs. 0 (0, 1), <italic toggle="no">p</italic>&#x02009;&#x0003c;&#x02009;0.001). Cardioembolic strokes were more frequent in women, even after PSM. Despite this, women had better odds of achieving good outcomes at discharge (adjusted OR 1.20, 95% CI 1.04&#x02013;1.38, <italic toggle="no">p</italic>&#x02009;=&#x02009;0.013), but not at follow&#x02010;up (OR 0.91, 95% CI 0.78&#x02013;1.05, <italic toggle="no">p</italic>&#x02009;=&#x02009;0.193). Both PSM analyses confirmed these findings.</p></sec><sec id="ene70092-sec-0004"><title>Conclusions</title><p>While women demonstrated better short&#x02010;term functional outcomes after EVT, these benefits diminished in follow&#x02010;up. The persistence of cardioembolic stroke in women suggests potential sex&#x02010;specific mechanisms. Understanding and addressing sex&#x02010;related differences in stroke is essential to optimize acute stroke care and improve outcomes. Future studies should explore biological and socio&#x02010;economic factors influencing sex&#x02010;related differences.</p></sec><sec id="ene70092-sec-0005"><title>Trial Registration</title><p>
<ext-link xlink:href="http://clinicaltrials.gov" ext-link-type="uri">ClinicalTrials.gov</ext-link> identifier: NCT03356392</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="ene70092-kwd-0001">acute management</kwd><kwd id="ene70092-kwd-0002">endovascular thrombectomy</kwd><kwd id="ene70092-kwd-0003">female</kwd><kwd id="ene70092-kwd-0004">intensive care</kwd><kwd id="ene70092-kwd-0005">intravenous thrombolysis</kwd><kwd id="ene70092-kwd-0006">sex&#x02010;related differences</kwd><kwd id="ene70092-kwd-0007">stroke</kwd></kwd-group><counts><fig-count count="4"/><table-count count="1"/><page-count count="13"/><word-count count="7200"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:26.02.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="ene70092-ntgp-0001"><fn fn-type="funding" id="ene70092-note-0001"><p>
<bold>Funding:</bold> The authors received no specific funding for this work.</p></fn></fn-group></notes></front><body id="ene70092-body-0001"><def-list list-content="abbreviations" id="ene70092-dl-0001"><title>Abbreviations</title><def-item><term id="ene70092-li-0001">(p)mRS</term><def id="ene70092-li-0002"><p>premorbid modified Rankin Scale</p></def></def-item><def-item><term id="ene70092-li-0003">ACA</term><def id="ene70092-li-0004"><p>anterior cerebral artery</p></def></def-item><def-item><term id="ene70092-li-0005">AE</term><def id="ene70092-li-0006"><p>adverse event</p></def></def-item><def-item><term id="ene70092-li-0007">AF</term><def id="ene70092-li-0008"><p>atrial fibrillation</p></def></def-item><def-item><term id="ene70092-li-0009">BA</term><def id="ene70092-li-0010"><p>basilary artery</p></def></def-item><def-item><term id="ene70092-li-0011">CT</term><def id="ene70092-li-0012"><p>computed tomography</p></def></def-item><def-item><term id="ene70092-li-0013">CTA</term><def id="ene70092-li-0014"><p>CT angiography</p></def></def-item><def-item><term id="ene70092-li-0015">ECASS II/III</term><def id="ene70092-li-0016"><p>European Cooperative Acute Stroke Study part II/III</p></def></def-item><def-item><term id="ene70092-li-0017">EVT</term><def id="ene70092-li-0018"><p>endovascular thrombectomy</p></def></def-item><def-item><term id="ene70092-li-0019">FLR</term><def id="ene70092-li-0020"><p>flow restoration</p></def></def-item><def-item><term id="ene70092-li-0021">GRO</term><def id="ene70092-li-0022"><p>groin puncture</p></def></def-item><def-item><term id="ene70092-li-0023">GSR&#x02010;ET</term><def id="ene70092-li-0024"><p>German Stroke Registry&#x02010;Endovascular Treatment</p></def></def-item><def-item><term id="ene70092-li-0025">ICA</term><def id="ene70092-li-0026"><p>internal carotid artery</p></def></def-item><def-item><term id="ene70092-li-0027">ICH</term><def id="ene70092-li-0028"><p>intracerebral hemorrhage</p></def></def-item><def-item><term id="ene70092-li-0029">IVT</term><def id="ene70092-li-0030"><p>intravenous thrombolysis</p></def></def-item><def-item><term id="ene70092-li-0031">LSW</term><def id="ene70092-li-0032"><p>last seen well</p></def></def-item><def-item><term id="ene70092-li-0033">LVO</term><def id="ene70092-li-0034"><p>large vessel occlusion</p></def></def-item><def-item><term id="ene70092-li-0035">MCA</term><def id="ene70092-li-0036"><p>middle cerebral artery</p></def></def-item><def-item><term id="ene70092-li-0037">mTICI</term><def id="ene70092-li-0038"><p>modified Thrombolysis in Cerebral Infarction score</p></def></def-item><def-item><term id="ene70092-li-0039">NIHSS</term><def id="ene70092-li-0040"><p>National Institutes of Health Stroke Scale</p></def></def-item><def-item><term id="ene70092-li-0041">PCA</term><def id="ene70092-li-0042"><p>posterior cerebral artery</p></def></def-item><def-item><term id="ene70092-li-0043">PSM</term><def id="ene70092-li-0044"><p>propensity score matching</p></def></def-item><def-item><term id="ene70092-li-0045">RCT</term><def id="ene70092-li-0046"><p>randomized controlled trials</p></def></def-item><def-item><term id="ene70092-li-0047">rtPA</term><def id="ene70092-li-0048"><p>recombinant tissue plasminogen activator</p></def></def-item><def-item><term id="ene70092-li-0049">SD</term><def id="ene70092-li-0050"><p>Standard deviation</p></def></def-item><def-item><term id="ene70092-li-0051">sICH</term><def id="ene70092-li-0052"><p>symptomatic ICH</p></def></def-item><def-item><term id="ene70092-li-0053">sICH</term><def id="ene70092-li-0054"><p>symptomatic intracranial hemorrhage</p></def></def-item><def-item><term id="ene70092-li-0055">SMD</term><def id="ene70092-li-0056"><p>standardized mean differences</p></def></def-item><def-item><term id="ene70092-li-0057">SO</term><def id="ene70092-li-0058"><p>symptom onset</p></def></def-item><def-item><term id="ene70092-li-0059">VA</term><def id="ene70092-li-0060"><p>vertebral artery</p></def></def-item></def-list><sec id="ene70092-sec-0006"><label>1</label><title>Introduction</title><p>Growing evidence underscores the importance of sex&#x02010;related differences in acute ischemic stroke, with women not only exhibiting a higher lifetime prevalence and worse outcomes but also a diminished quality of life after stroke compared to men [<xref rid="ene70092-bib-0001" ref-type="bibr">1</xref>, <xref rid="ene70092-bib-0002" ref-type="bibr">2</xref>, <xref rid="ene70092-bib-0003" ref-type="bibr">3</xref>, <xref rid="ene70092-bib-0004" ref-type="bibr">4</xref>]. Several major risk factors, including hypertension, smoking, and atrial fibrillation (AF) are more strongly associated with increased stroke incidence in women [<xref rid="ene70092-bib-0005" ref-type="bibr">5</xref>]. These differences may arise from unique physiological aspects in women, including coagulation pathways, immune response, and hormone exposure [<xref rid="ene70092-bib-0006" ref-type="bibr">6</xref>, <xref rid="ene70092-bib-0007" ref-type="bibr">7</xref>]. Despite often presenting with more severe symptoms and residing at similar distances to medical facilities, women are less frequently directed to comprehensive stroke centers and exhibit delays from symptom onset to hospital arrival, largely due to delayed calls to emergency services [<xref rid="ene70092-bib-0008" ref-type="bibr">8</xref>, <xref rid="ene70092-bib-0009" ref-type="bibr">9</xref>]. Once hospitalized, disparities in the utilization of acute reperfusion therapies may further exacerbate sex&#x02010;related differences in outcomes. Intravenous thrombolysis (IVT) and endovascular thrombectomy (EVT) for large vessel occlusion (LVO) have markedly improved stroke outcomes, effectively doubling the likelihood of favorable recovery in both anterior and posterior circulation stroke [<xref rid="ene70092-bib-0010" ref-type="bibr">10</xref>, <xref rid="ene70092-bib-0011" ref-type="bibr">11</xref>, <xref rid="ene70092-bib-0012" ref-type="bibr">12</xref>]. However, women are consistently underrepresented in these therapies. A meta&#x02010;analysis found women were 13% less likely to receive IVT [<xref rid="ene70092-bib-0013" ref-type="bibr">13</xref>]. Female sex was an independent predictor of worse 90&#x02010;day outcomes in lacunar stroke treated with IVT [<xref rid="ene70092-bib-0014" ref-type="bibr">14</xref>]. Women with LVO were less often selected for EVT, contributing to poorer outcomes [<xref rid="ene70092-bib-0015" ref-type="bibr">15</xref>, <xref rid="ene70092-bib-0016" ref-type="bibr">16</xref>]. Although randomized controlled trials (RCT) generally reported negligible sex&#x02010;related differences in EVT efficacy [<xref rid="ene70092-bib-0017" ref-type="bibr">17</xref>, <xref rid="ene70092-bib-0018" ref-type="bibr">18</xref>], observational studies and registry data often indicated worse outcomes for women [<xref rid="ene70092-bib-0019" ref-type="bibr">19</xref>, <xref rid="ene70092-bib-0020" ref-type="bibr">20</xref>, <xref rid="ene70092-bib-0021" ref-type="bibr">21</xref>, <xref rid="ene70092-bib-0022" ref-type="bibr">22</xref>, <xref rid="ene70092-bib-0023" ref-type="bibr">23</xref>]. These findings are often attributed to confounding factors such as older age and worse pre&#x02010;stroke functional status in women [<xref rid="ene70092-bib-0024" ref-type="bibr">24</xref>], highlighting the complexity of sex&#x02010;related differences in stroke outcomes. Beyond these, variations in clinical presentation, imaging characteristics, and periinterventional parameters may also play a role [<xref rid="ene70092-bib-0025" ref-type="bibr">25</xref>].</p><p>Our study aimed to address these gaps by comprehensively investigating sex&#x02010;related differences in clinical presentation, periinterventional parameters, and outcomes following EVT. Leveraging the prospectively collected data from the German Stroke Registry&#x02013;Endovascular Treatment (GSR&#x02010;ET), we minimized potential biases by employing propensity score matching (PSM) to adjust for confounders.</p></sec><sec sec-type="methods" id="ene70092-sec-0007"><label>2</label><title>Methods</title><sec id="ene70092-sec-0008"><label>2.1</label><title>Study Design and Ethics</title><p>This retrospective observational study analyzed data from the GSR&#x02010;ET (<ext-link xlink:href="https://www.clinicaltrials.gov" ext-link-type="uri">https://www.clinicaltrials.gov</ext-link>; NCT03356392), an ongoing, open&#x02010;label, prospective, multicenter registry [<xref rid="ene70092-bib-0026" ref-type="bibr">26</xref>, <xref rid="ene70092-bib-0027" ref-type="bibr">27</xref>]. Institutional review board approval was obtained from Ludwig Maximilian Universit&#x000e4;t, Munich, Germany (689&#x02010;15) and University of T&#x000fc;bingen (057/2016BO2) with informed consent provided. Local ethics approval were obtained according to site regulations. The analysis followed STROBE reporting guidelines (<xref rid="ene70092-supitem-0001" ref-type="supplementary-material">Supporting Information</xref>). Of 13.082 EVT patients in the GSR&#x02010;ET, <italic toggle="yes">n</italic>&#x02009;=&#x02009;1.186 patients were excluded (Figure&#x000a0;<xref rid="ene70092-fig-0001" ref-type="fig">1</xref>).</p><fig position="float" fig-type="FIGURE" id="ene70092-fig-0001"><label>FIGURE 1</label><caption><p>Flowchart of selection process. EVT, endovascular treatment; GSR&#x02010;ET, German Stroke Registry&#x02014;Endovascular Treatment; <italic toggle="yes">n</italic>, number; NIHSS, National Institutes of Health Stroke Scale; pmRS, pre&#x02010;stroke modified Rankin Scale.</p></caption><graphic xlink:href="ENE-32-e70092-g004" position="anchor" id="jats-graphic-1"/></fig></sec><sec id="ene70092-sec-0009"><label>2.2</label><title>Definitions</title><p>Stroke severity was assessed using the National Institutes of Health Stroke Scale (NIHSS) and functional dependence using the modified Rankin Scale (mRS). Good outcome was defined as mRS 0&#x02013;2 and excellent outcome as mRS 0&#x02013;1 according to the ESO (European Stroke Organisation) definition (<ext-link xlink:href="https://eso-stroke.org/outcome-measures-stroke-modified-rankin-scale-ordinal-logistic-regression/" ext-link-type="uri">https://eso&#x02010;stroke.org/outcome&#x02010;measures&#x02010;stroke&#x02010;modified&#x02010;rankin&#x02010;scale&#x02010;ordinal&#x02010;logistic&#x02010;regression/</ext-link>). Substantial neurological improvement was defined as a difference between admission and discharge NIHSS of &#x02265;&#x02009;8 points or discharge NIHSS of &#x02264;&#x02009;1 [<xref rid="ene70092-bib-0028" ref-type="bibr">28</xref>, <xref rid="ene70092-bib-0029" ref-type="bibr">29</xref>]. Reperfusion success was measured by the modified Thrombolysis in Cerebral Infarction (mTICI) score [<xref rid="ene70092-bib-0030" ref-type="bibr">30</xref>]; mTICI 2b&#x02013;3 was rated as successful reperfusion. A modified CHA2DS2&#x02010;VASc Score estimated cardiovascular risk, adjusted for data variability including the following factors: age (&#x02265;&#x02009;75&#x02009;years: 2 points, 65&#x02013;74&#x02009;years: 1 point), female sex (1 point), hypertension (1 point), diabetes mellitus (1 point) and previous stroke (2 points). Intracerebral hemorrhage (ICH) was defined as any hemorrhage in routine CT postinterventional imaging 24&#x02009;h after EVT according to the European Cooperative Acute Stroke Study part II (ECASS II) [<xref rid="ene70092-bib-0031" ref-type="bibr">31</xref>], irrespective of the presence of new clinical symptoms, while symptomatic ICH (sICH) was defined as any ICH on follow&#x02010;up imaging leading to an increase in NIHSS of &#x02265;&#x02009;4 points from baseline to 24&#x02009;h&#x02010;value (ECASS III) or death [<xref rid="ene70092-bib-0032" ref-type="bibr">32</xref>].</p></sec><sec id="ene70092-sec-0010"><label>2.3</label><title>Outcomes</title><p>Primary outcome was mRS at discharge and 90&#x02010;day follow&#x02010;up. Secondary outcomes included NIHSS at discharge, (peri&#x02010;)procedural time intervals, ICH and sICH, and periprocedural and in&#x02010;hospital complications.</p></sec><sec id="ene70092-sec-0011"><label>2.4</label><title>Statistical Analysis</title><p>Continuous variables were tested for normal distribution using the Kolmogorov&#x02013;Smirnov test. Normally distributed data were presented as mean and standard deviation (&#x000b1;&#x02009;SD), while non&#x02010;normally distributed data were presented as median with interquartile range (IQR) with 25th and 75th percentiles or counts and percentages. Clinical characteristics, imaging, periprocedural times, and outcomes were compared using the Kruskal&#x02013;Wallis or median test. Continuous variables were assessed with the Mann&#x02013;Whitney <italic toggle="yes">U</italic> test, and categorical data with the Chi&#x02010;square test. Binary logistic regression analysis evaluated good (mRS 0&#x02013;2) and excellent (mRS 0&#x02013;1) outcome, and mortality (mRS 6) at discharge and follow&#x02010;up, including significant univariate variables and known predictors. Model fit was assessed with the Hosmer&#x02013;Lemeshow test, using a binomial distribution and logit function.</p><p>Propensity score matching (PSM) was performed using two approaches: The first PSM cohort used a logistic regression model to estimate the propensity scores based on age, pmRS, and NIHSS at admission, with a caliper width of 0.1 standard deviations of the logit of the propensity score, without replacement. The second PSM cohort employed 1:1 nearest neighbor matching without replacement, based on age, pmRS, NIHSS at admission, and comorbidities (hypertension, AF, dyslipidemia, diabetes mellitus, smoking). Missing categorical variables were imputed using a dummy variable to maintain data integrity. A caliper of 0.01 was employed. The effectiveness of the matching procedure was assessed by comparing the standardized mean differences (SMD) with a SMD &#x0003c;&#x02009;0.1 being indicative of adequate balance. For the matched cohort, logistic or conditional regression analysis evaluated the association between gender and stroke outcomes, presenting adjusted odds ratios (aORs) with 95% confidence intervals (CIs).</p><p>Statistical analyses were conducted using SPSS Version 29.0.1.1 and R 4.3.2. The statistical significance level was set to <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></sec></sec><sec sec-type="results" id="ene70092-sec-0012"><label>3</label><title>Results</title><sec id="ene70092-sec-0013"><label>3.1</label><title>Patient Characteristics</title><p>Of the 11.896 EVT patients in our cohort, 6.093 (51.2%) were female. Women were older (mean age 76.3&#x02009;&#x000b1;&#x02009;12.7 vs. 70.2&#x02009;&#x000b1;&#x02009;12.9&#x02009;years, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic toggle="yes">d</italic>&#x02009;=&#x02009;0.48) and had greater pre&#x02010;stroke disability (median pmRS 0 [IQR 0, 2] vs. 0 [IQR 0, 1], <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic toggle="yes">d</italic>&#x02009;=&#x02009;0.23). Women also had a higher prevalence of hypertension (79.5% vs. 73.9%, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic toggle="yes">V</italic>&#x02009;=&#x02009;0.14), AF (46.4% vs. 34.6%. <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic toggle="yes">V</italic>&#x02009;=&#x02009;0.25), and were less likely to be (current/previous) smoker (16.5% vs. 33.6%, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic toggle="yes">V</italic>&#x02009;=&#x02009;0.41). Additionally, women presented with higher baseline NIHSS (median 15 [IQR 9, 19] vs. 14 [IQR 9, 18], <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic toggle="yes">d</italic>&#x02009;=&#x02009;0.07), indicating more severe strokes at admission.</p><p>Cardioembolism was more common in women (55.7% vs. 41.9%, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic toggle="yes">V</italic>&#x02009;=&#x02009;0.26), while large&#x02010;artery atherosclerosis was more frequent in men (21.5% vs. 32.5%, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic toggle="yes">V</italic>&#x02009;=&#x02009;0.23).</p><p>Women were less likely to receive IVT (46.9% vs. 49.0%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.019, <italic toggle="yes">V</italic>&#x02009;=&#x02009;0.04). Successful reperfusion rates were slightly lower in women (83.3% vs. 84.6%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.030, <italic toggle="yes">V</italic>&#x02009;=&#x02009;0.04). Periprocedural times and complications did not differ significantly between sexes, except for a difference regarding the time from admission to flow restoration (162 [108, 245] vs. 164 [113, 252] min, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.027, <italic toggle="yes">d</italic>&#x02009;=&#x02009;0.05).</p><p>Differences were also observed in outcomes: women had a higher mRS at discharge (median 4 [IQR 2.5] vs. 4 [IQR 2.5], <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic toggle="yes">d</italic>&#x02009;=&#x02009;0.11) and follow&#x02010;up (median 4 [IQR 2.6] vs. 3 [IQR 1.6], <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic toggle="yes">d</italic>&#x02009;=&#x02009;0.22). Mortality both at discharge (19.0% vs. 15.0%, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic toggle="yes">V</italic>&#x02009;=&#x02009;0.11) and follow&#x02010;up (29.0% vs. 23.4%, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic toggle="yes">V</italic>&#x02009;=&#x02009;0.14) was higher in women. Women had lower rates of good (26.2% vs. 29.1%, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic toggle="yes">V</italic>&#x02009;=&#x02009;0.07) and excellent outcomes (14.4% vs. 16.6%, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic toggle="yes">V</italic>&#x02009;=&#x02009;0.06) at discharge, as well as at follow&#x02010;up (good outcome: 25.5% vs. 34.3%, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic toggle="yes">V</italic>&#x02009;=&#x02009;0.21; excellent outcome: 17.0% vs. 24.0%, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic toggle="yes">V</italic>&#x02009;=&#x02009;0.20). For details see Table&#x000a0;<xref rid="ene70092-tbl-0001" ref-type="table">1</xref> and Figure&#x000a0;<xref rid="ene70092-fig-0002" ref-type="fig">2A</xref>.</p><table-wrap position="float" id="ene70092-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Baseline: Periprocedural and outcome characteristics of males and females in the GSR&#x02010;ET (unmatched cohort).</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">GSR&#x02010;ET <italic toggle="yes">n</italic>&#x02009;=&#x02009;11.896</th><th align="center" valign="bottom" rowspan="1" colspan="1">Female <italic toggle="yes">n</italic>&#x02009;=&#x02009;6.093 (51.2%)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Male <italic toggle="yes">n</italic>&#x02009;=&#x02009;5.803 (48.8%)</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">Effect size (cohens <italic toggle="yes">d</italic> or cramers <italic toggle="yes">V</italic>)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age mean&#x02009;&#x000b1;&#x02009;SD (years)</td><td align="center" valign="top" rowspan="1" colspan="1">73.3&#x02009;&#x000b1;&#x02009;13.2</td><td align="center" valign="top" rowspan="1" colspan="1">76.3&#x02009;&#x000b1;&#x02009;12.8</td><td align="center" valign="top" rowspan="1" colspan="1">70.2&#x02009;&#x000b1;&#x02009;12.9</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.48</td></tr><tr><td align="left" colspan="6" valign="top" rowspan="1">Comorbidities, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hypertension</td><td align="center" valign="top" rowspan="1" colspan="1">9091 (76.4)</td><td align="center" valign="top" rowspan="1" colspan="1">4843 (79.5)</td><td align="center" valign="top" rowspan="1" colspan="1">4248 (73.2)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.14</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">DM</td><td align="center" valign="top" rowspan="1" colspan="1">2596 (21.8)</td><td align="center" valign="top" rowspan="1" colspan="1">1288 (21.1)</td><td align="center" valign="top" rowspan="1" colspan="1">1308 (22.5)</td><td align="center" valign="top" rowspan="1" colspan="1">0.063</td><td align="center" valign="top" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Dyslipidemia</td><td align="center" valign="top" rowspan="1" colspan="1">4772 (40.1)</td><td align="center" valign="top" rowspan="1" colspan="1">2330 (38.2)</td><td align="center" valign="top" rowspan="1" colspan="1">2442 (42.1)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">AF</td><td align="center" valign="top" rowspan="1" colspan="1">4835 (40.6)</td><td align="center" valign="top" rowspan="1" colspan="1">2830 (46.4)</td><td align="center" valign="top" rowspan="1" colspan="1">2005 (34.6)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.25</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Smoker</td><td align="center" valign="top" rowspan="1" colspan="1">2358 (24.8)</td><td align="center" valign="top" rowspan="1" colspan="1">1005 (16.5)</td><td align="center" valign="top" rowspan="1" colspan="1">1953 (33.6)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.41</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Previous stroke</td><td align="center" valign="top" rowspan="1" colspan="1">837 (7.0)</td><td align="center" valign="top" rowspan="1" colspan="1">419 (6.9)</td><td align="center" valign="top" rowspan="1" colspan="1">418 (7.2)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Anticoagulation at admission</td><td align="center" valign="top" rowspan="1" colspan="1">2523 (21.2)</td><td align="center" valign="top" rowspan="1" colspan="1">1409 (23.1)</td><td align="center" valign="top" rowspan="1" colspan="1">1114 (19.2)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.10</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Modified CHAD2DS2&#x02010;VASc Score</td><td align="center" valign="top" rowspan="1" colspan="1">2.6&#x02009;&#x000b1;&#x02009;1.3</td><td align="center" valign="top" rowspan="1" colspan="1">2.9&#x02009;&#x000b1;&#x02009;1.2</td><td align="center" valign="top" rowspan="1" colspan="1">2.4&#x02009;&#x000b1;&#x02009;1.3</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.37</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">Etiology, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.060</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.03</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Large&#x02010;artery atherosclerosis (embolus/thrombosis)</td><td align="center" valign="top" rowspan="1" colspan="1">3193 (26.8)</td><td align="center" valign="top" rowspan="1" colspan="1">1309 (21.5)</td><td align="center" valign="top" rowspan="1" colspan="1">1884 (32.5)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cardioembolism</td><td align="center" valign="top" rowspan="1" colspan="1">5823 (48.9)</td><td align="center" valign="top" rowspan="1" colspan="1">3392 (55.7)</td><td align="center" valign="top" rowspan="1" colspan="1">2431 (41.9)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Stroke of other determined etiology</td><td align="center" valign="top" rowspan="1" colspan="1">672 (5.6)</td><td align="center" valign="top" rowspan="1" colspan="1">276 (4.5)</td><td align="center" valign="top" rowspan="1" colspan="1">396 (6.8)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Stroke of undetermined etiology</td><td align="center" valign="top" rowspan="1" colspan="1">2208 (18.6)</td><td align="center" valign="top" rowspan="1" colspan="1">1116 (18.3)</td><td align="center" valign="top" rowspan="1" colspan="1">1092 (18.8)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="6" valign="top" rowspan="1">Clinical characteristics at admission</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">pmRS, median (IQR)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0, 2)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0, 2)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0, 1)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.23</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Baseline NIHSS, median (IQR)</td><td align="center" valign="top" rowspan="1" colspan="1">14 (9, 19)</td><td align="center" valign="top" rowspan="1" colspan="1">15 (9, 19)</td><td align="center" valign="top" rowspan="1" colspan="1">14 (9, 18)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.07</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Severe stroke (NIHSS&#x02009;&#x0003e;&#x02009;15), <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">5076 (42.7)</td><td align="center" valign="top" rowspan="1" colspan="1">2684 (44.1)</td><td align="center" valign="top" rowspan="1" colspan="1">2392 (41.2)</td><td align="center" valign="top" rowspan="1" colspan="1">0.002<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.06</td></tr><tr><td align="left" colspan="6" valign="top" rowspan="1">Imaging data, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Anterior circulation</td><td align="center" valign="top" rowspan="1" colspan="1">10,581 (88.9)</td><td align="center" valign="top" rowspan="1" colspan="1">5545 (91.0)</td><td align="center" valign="top" rowspan="1" colspan="1">5036 (86.8)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.13</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Posterior circulation</td><td align="center" valign="top" rowspan="1" colspan="1">1330 (11.2)</td><td align="center" valign="top" rowspan="1" colspan="1">556 (9.1)</td><td align="center" valign="top" rowspan="1" colspan="1">774 (13.3)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.13</td></tr><tr><td align="left" colspan="6" valign="top" rowspan="1">Treated vessel of occlusion, <italic toggle="yes">n</italic> (%)<xref rid="ene70092-note-0003" ref-type="table-fn">
<sup>a</sup>
</xref>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">BA</td><td align="center" valign="top" rowspan="1" colspan="1">983 (8.2)</td><td align="center" valign="top" rowspan="1" colspan="1">413 (6.8)</td><td align="center" valign="top" rowspan="1" colspan="1">570 (9.8)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.11</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">VA</td><td align="center" valign="top" rowspan="1" colspan="1">256 (2.2)</td><td align="center" valign="top" rowspan="1" colspan="1">65 (1.1)</td><td align="center" valign="top" rowspan="1" colspan="1">191 (3.3)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.15</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">PCA</td><td align="center" valign="top" rowspan="1" colspan="1">384 (3.2)</td><td align="center" valign="top" rowspan="1" colspan="1">185 (3.0)</td><td align="center" valign="top" rowspan="1" colspan="1">199 (3.4)</td><td align="center" valign="top" rowspan="1" colspan="1">0.228</td><td align="center" valign="top" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ACA</td><td align="center" valign="top" rowspan="1" colspan="1">365 (3.1)</td><td align="center" valign="top" rowspan="1" colspan="1">184 (3.0)</td><td align="center" valign="top" rowspan="1" colspan="1">181 (3.1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.759</td><td align="center" valign="top" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">MCA M1</td><td align="center" valign="top" rowspan="1" colspan="1">5967 (50.2)</td><td align="center" valign="top" rowspan="1" colspan="1">1295 (21.3)</td><td align="center" valign="top" rowspan="1" colspan="1">1132 (19.5)</td><td align="center" valign="top" rowspan="1" colspan="1">0.017<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.05</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">MCA M2</td><td align="center" valign="top" rowspan="1" colspan="1">2843 (23.9)</td><td align="center" valign="top" rowspan="1" colspan="1">1444 (23.7)</td><td align="center" valign="top" rowspan="1" colspan="1">1399 (24.1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.611</td><td align="center" valign="top" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ICA extracranial</td><td align="center" valign="top" rowspan="1" colspan="1">793 (6.7)</td><td align="center" valign="top" rowspan="1" colspan="1">298 (4.9)</td><td align="center" valign="top" rowspan="1" colspan="1">495 (8.5)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.15</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ICA intracranial/carotid&#x02010;T</td><td align="center" valign="top" rowspan="1" colspan="1">2639 (22.2)</td><td align="center" valign="top" rowspan="1" colspan="1">1345 (22.0)</td><td align="center" valign="top" rowspan="1" colspan="1">1294 (22.3)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.04</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Multiple occlusions</td><td align="center" valign="top" rowspan="1" colspan="1">1696 (14.3)</td><td align="center" valign="top" rowspan="1" colspan="1">760 (12.5)</td><td align="center" valign="top" rowspan="1" colspan="1">936 (16.1)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.18</td></tr><tr><td align="left" colspan="6" valign="top" rowspan="1">Treatment, <italic toggle="yes">n</italic> (%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">IVT</td><td align="center" valign="top" rowspan="1" colspan="1">5703 (47.9)</td><td align="center" valign="top" rowspan="1" colspan="1">2857 (46.9)</td><td align="center" valign="top" rowspan="1" colspan="1">2846 (49.0)</td><td align="center" valign="top" rowspan="1" colspan="1">0.019<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Successful reperfusion, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">9981 (83.9)</td><td align="center" valign="top" rowspan="1" colspan="1">5074 (83.3)</td><td align="center" valign="top" rowspan="1" colspan="1">4907 (84.6)</td><td align="center" valign="top" rowspan="1" colspan="1">0.030<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Number of passages, mean&#x02009;&#x000b1;&#x02009;SD</td><td align="center" valign="top" rowspan="1" colspan="1">2.1&#x02009;&#x000b1;&#x02009;1.7</td><td align="center" valign="top" rowspan="1" colspan="1">2.1&#x02009;&#x000b1;&#x02009;1.7</td><td align="center" valign="top" rowspan="1" colspan="1">2.2&#x02009;&#x000b1;&#x02009;1.8</td><td align="center" valign="top" rowspan="1" colspan="1">0.087</td><td align="center" valign="top" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" colspan="6" valign="top" rowspan="1">Time intervals (min) median (IQR)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Symptom onset to admission</td><td align="center" valign="top" rowspan="1" colspan="1">30 (17, 57)</td><td align="center" valign="top" rowspan="1" colspan="1">30 (17, 58)</td><td align="center" valign="top" rowspan="1" colspan="1">28 (17, 56)</td><td align="center" valign="top" rowspan="1" colspan="1">0.058</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.046</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Door to needle</td><td align="center" valign="top" rowspan="1" colspan="1">30 (22, 42)</td><td align="center" valign="top" rowspan="1" colspan="1">31 (22, 43)</td><td align="center" valign="top" rowspan="1" colspan="1">30 (23, 42)</td><td align="center" valign="top" rowspan="1" colspan="1">0.154</td><td align="center" valign="top" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Admission to flow restoration</td><td align="center" valign="top" rowspan="1" colspan="1">163 (110, 249)</td><td align="center" valign="top" rowspan="1" colspan="1">162 (108, 245)</td><td align="center" valign="top" rowspan="1" colspan="1">164 (113, 252)</td><td align="center" valign="top" rowspan="1" colspan="1">0.027<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Symptom onset OR time of recognition of stroke till flow restoration</td><td align="center" valign="top" rowspan="1" colspan="1">235 (159, 350)</td><td align="center" valign="top" rowspan="1" colspan="1">238 (160, 350)</td><td align="center" valign="top" rowspan="1" colspan="1">234 (158, 349)</td><td align="center" valign="top" rowspan="1" colspan="1">0.474</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.02</td></tr><tr><td align="left" colspan="6" valign="top" rowspan="1">Periprocedural complications</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Any AE, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">2348 (19.7)</td><td align="center" valign="top" rowspan="1" colspan="1">1242 (20.4)</td><td align="center" valign="top" rowspan="1" colspan="1">1106 (19.1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.077</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.03</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">sICH, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">168 (1.4)</td><td align="center" valign="top" rowspan="1" colspan="1">96 (1.6)</td><td align="center" valign="top" rowspan="1" colspan="1">72 (1.2)</td><td align="center" valign="top" rowspan="1" colspan="1">0.124</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.03</td></tr><tr><td align="left" colspan="6" valign="top" rowspan="1">In&#x02010;hospital complications and clinical course</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Recurrent stroke first 24&#x02009;h, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">670 (5.6)</td><td align="center" valign="top" rowspan="1" colspan="1">317 (5.2)</td><td align="center" valign="top" rowspan="1" colspan="1">253 (6.1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.039<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Any AE during hospital stay, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">6840 (57.5)</td><td align="center" valign="top" rowspan="1" colspan="1">3509 (57.6)</td><td align="center" valign="top" rowspan="1" colspan="1">3331 (57.4)</td><td align="center" valign="top" rowspan="1" colspan="1">0.729</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.01</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">sICH during hospital stay, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">914 (7.7)</td><td align="center" valign="top" rowspan="1" colspan="1">475 (7.8)</td><td align="center" valign="top" rowspan="1" colspan="1">439 (7.6)</td><td align="center" valign="top" rowspan="1" colspan="1">0.590</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.01</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Myocardial infarction during hospital stay, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">203 (1.7)</td><td align="center" valign="top" rowspan="1" colspan="1">82 (1.3)</td><td align="center" valign="top" rowspan="1" colspan="1">121 (2.1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.002<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hospital stay, mean&#x02009;&#x000b1;&#x02009;SD (days)</td><td align="center" valign="top" rowspan="1" colspan="1">10.6&#x02009;&#x000b1;&#x02009;8.5</td><td align="center" valign="top" rowspan="1" colspan="1">10.2&#x02009;&#x000b1;&#x02009;8.0</td><td align="center" valign="top" rowspan="1" colspan="1">10.9&#x02009;&#x000b1;&#x02009;9.0</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" colspan="6" valign="top" rowspan="1">Outcome at discharge (<italic toggle="yes">n</italic>&#x02009;=&#x02009;552 missing values, 4.6%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">NIHSS, median (IQR)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (2, 12)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (2, 12)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (2, 12)</td><td align="center" valign="top" rowspan="1" colspan="1">0.009<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.05</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Substantial neurological improvement, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">5440 (45.7)</td><td align="center" valign="top" rowspan="1" colspan="1">2656 (43.6)</td><td align="center" valign="top" rowspan="1" colspan="1">2784 (48.0)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">mRS, median (IQR)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (2, 5)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (2, 5)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (2, 5)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.11</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Good outcome, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">3285 (27.6)</td><td align="center" valign="top" rowspan="1" colspan="1">1596 (26.2)</td><td align="center" valign="top" rowspan="1" colspan="1">1689 (29.1)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Excellent outcome, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">1845 (15.5)</td><td align="center" valign="top" rowspan="1" colspan="1">880 (14.4)</td><td align="center" valign="top" rowspan="1" colspan="1">965 (16.6)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Mortality (mRS 6), <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">2029 (17.1)</td><td align="center" valign="top" rowspan="1" colspan="1">1156 (19.0)</td><td align="center" valign="top" rowspan="1" colspan="1">873 (15.0)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.11</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">Transfer to, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;&#x02009;0.001<xref rid="ene70092-note-0004" ref-type="table-fn">*</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.17</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Home, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">2576 (21.7)</td><td align="center" valign="top" rowspan="1" colspan="1">1181 (19.4)</td><td align="center" valign="top" rowspan="1" colspan="1">1395 (24.0)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Rehabilitation, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">5182 (43.6)</td><td align="center" valign="top" rowspan="1" colspan="1">2593 (42.6)</td><td align="center" valign="top" rowspan="1" colspan="1">2589 (44.6)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Other hospital, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">1800 (15.1)</td><td align="center" valign="top" rowspan="1" colspan="1">922 (15.1)</td><td align="center" valign="top" rowspan="1" colspan="1">878 (15.1)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Nursing home, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">356 (3.0)</td><td align="center" valign="top" rowspan="1" colspan="1">257 (4.2)</td><td align="center" valign="top" rowspan="1" colspan="1">99 (1.7)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Unknown, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1">1982 (16.7)</td><td align="center" valign="top" rowspan="1" colspan="1">1140 (18.7)</td><td align="center" valign="top" rowspan="1" colspan="1">842 (14.5)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot id="ene70092-ntgp-0002"><fn id="ene70092-note-0002"><p>Abbreviations: ACA, anterior cerebral artery; AE, adverse event; AF, atrial fibrillation; BA, basilar artery; DM, diabetes mellitus; EVT, endovascular thrombectomy; GSR&#x02010;ET, German Stroke Registry&#x02010;Endovascular Treatment; ICA, internal carotid artery; IVT, intravenous thrombolysis; MCA, middle cerebral artery; (p)mRS, (premorbid) modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; PCA, posterior cerebral artery; sICH, symptomatic intracranial hemorrhage; VA, vertebral artery.</p></fn><fn id="ene70092-note-0003"><label>
<sup>a</sup>
</label><p>Multiple occlusions possible.</p></fn><fn id="ene70092-note-0004"><label>*</label><p>Significant.</p></fn></table-wrap-foot></table-wrap><fig position="float" fig-type="FIGURE" id="ene70092-fig-0002"><label>FIGURE 2</label><caption><p>Functional outcome at follow&#x02010;up. (A) Unmatched cohort, (B) Cohort 1, (C) Cohort 2. mRS, modified Rankin Scale.</p></caption><graphic xlink:href="ENE-32-e70092-g002" position="anchor" id="jats-graphic-3"/></fig></sec><sec id="ene70092-sec-0014"><label>3.2</label><title>Univariate Binary Logistic Regression Analyses: Unmatched Cohort</title><p>Female sex was consistently associated with worse outcomes compared to males. Females had lower odds of achieving a good outcome both at discharge (OR&#x02009;=&#x02009;0.63, 95% CI 0.58&#x02013;0.69, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001) and follow&#x02010;up (OR&#x02009;=&#x02009;0.63, 95% CI 0.58&#x02013;0.69, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001). Age, higher pre&#x02010;stroke disability, and higher NIHSS at admission were also significant predictors of poorer outcomes. Hypertension and diabetes further decreased the likelihood of a good outcome, while smoking surprisingly increased it. Successful reperfusion significantly improved the chances of a good outcome. Regarding mortality, female sex was linked to higher odds both at discharge (OR&#x02009;=&#x02009;1.32, 95% CI 1.20&#x02013;1.45, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001) and follow&#x02010;up (OR&#x02009;=&#x02009;1.36, 95% CI 1.25&#x02013;1.48, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001). Older age, higher pmRS, higher NIHSS, hypertension, and diabetes were all significant predictors of increased mortality. Conversely, smoking was associated with lower mortality. Successful reperfusion substantially reduced the risk of mortality.</p></sec><sec id="ene70092-sec-0015"><label>3.3</label><title>Multivariable Binary Logistic Regression: Unmatched Cohort</title><p>Logistic regression analysis revealed that women had higher odds of achieving good (OR&#x02009;=&#x02009;1.25, 95% CI: 1.11&#x02013;1.41, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001) and excellent outcomes at discharge (OR&#x02009;=&#x02009;1.21, 95% CI: 1.05&#x02013;1.39, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.007) compared to men. Other significant predictors for good outcomes included younger age, lower pmRS, lower NIHSS at admission, IVT treatment, successful reperfusion, absence of sICH, fewer complications, and lower modified CHAD2DS2&#x02010;VASc. At follow&#x02010;up, female sex was not a significant predictor for good (OR 0.94, 95% CI 0.83&#x02013;1.07, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.349) or excellent (OR 0.93, 95% CI 0.82&#x02013;1.06, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.294) outcomes. For details, see Figure&#x000a0;<xref rid="ene70092-fig-0003" ref-type="fig">3A,B</xref>. For mortality both at discharge and follow&#x02010;up, sex was not a significant predictor (OR&#x02009;=&#x02009;1.04, 95% CI: 0.89&#x02013;1.21, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.647 and OR 0.92, 95% CI: 0.81&#x02013;1.06, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.241). For details, see Figure&#x000a0;<xref rid="ene70092-fig-0003" ref-type="fig">3C</xref>.</p><fig position="float" fig-type="FIGURE" id="ene70092-fig-0003"><label>FIGURE 3</label><caption><p>Predictors of outcome at discharge and follow&#x02010;up in multivariable binary logistic regression analyses (unmatched cohort). (A) Predictors of good outcome at discharge and follow&#x02010;up. (B) Predictors of excellent outcome at discharge and follow&#x02010;up. (C) Predictors of mortality at discharge and follow&#x02010;up. IVT, intravenous thrombolysis; NIHSS, National Institutes of Health Stroke Scale; (p)mRS, (premorbid) modified Rankin Scale; sICH, symptomatic intracranial hemorrhage. #Time from symptom onset OR time of recognition of stroke until flow restoration [min]. *Significant.</p></caption><graphic xlink:href="ENE-32-e70092-g003" position="anchor" id="jats-graphic-5"/></fig><sec id="ene70092-sec-0016"><label>3.3.1</label><title>
<styled-content style="fixed-case" toggle="no">PSM</styled-content> Cohort 1</title><p>The first PSM cohort included 8.475 patients (49.9% women). Women had lower rates of dyslipidemia (38.0% vs. 43.1%, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, SMD&#x02009;=&#x02009;&#x02212;0.102), diabetes (20.9% vs. 23.5%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.004, SMD&#x02009;=&#x02009;&#x02212;0.058), and smoking (19.8% vs. 29.5%, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, SMD&#x02009;=&#x02009;&#x02212;0.196), but higher rates of AF (42.5% vs. 39.4%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.005, SMD&#x02009;=&#x02009;0.062). Subsequently, cardioembolic (51.4% vs. 46.4%, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001) and anterior circulation strokes (90.7% vs. 87.4%, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, SMD&#x02009;=&#x02009;0.035) were more common in women. Rates of IVT, completed EVT, and successful reperfusion were similar between sexes. Women experienced more AE at all (20.9% vs. 18.9%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.020, SMD&#x02009;=&#x02009;0.004), while the incidence of sICH was slightly lower compared to men (6.1% vs. 7.9%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.002). Women had a shorter median time from admission to flow restoration (144&#x02009;min [IQR 99, 216] vs. 161&#x02009;min [IQR 112, 249], <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001). Both sexes had similar NIHSS at discharge (median 5 [IQR 2, 12] for both, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.771), while substantial neurological improvement was slightly higher in women (46.3% vs. 45.8%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.031). Consequently, women had higher odds of good outcomes at discharge (28.5% vs. 26.7%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.022), but lower odds of excellent outcomes at follow&#x02010;up (19.8% vs. 21.8%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.021) (Table&#x000a0;<xref rid="ene70092-supitem-0001" ref-type="supplementary-material">S1</xref> and Figure&#x000a0;<xref rid="ene70092-fig-0002" ref-type="fig">2B</xref>).</p><p>Univariate analysis showed female sex was associated with higher odds of substantial neurological improvement (OR&#x02009;=&#x02009;1.10, 95% CI: 1.01&#x02013;1.21, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.031) and good outcome at discharge (OR&#x02009;=&#x02009;1.12, 95% CI: 1.02&#x02013;1.23, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.022). Conversely, at follow&#x02010;up, female sex had lower odds of achieving an excellent outcome (OR&#x02009;=&#x02009;0.88, 95% CI: 0.79&#x02013;0.98, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.021) (Table&#x000a0;<xref rid="ene70092-supitem-0001" ref-type="supplementary-material">S2</xref>).</p><p>Multivariate logistic regression showed higher odds of achieving good (OR&#x02009;=&#x02009;1.20, 95% CI: 1.04&#x02013;1.38, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.013) and excellent (OR&#x02009;=&#x02009;1.19, 95% CI: 1.02&#x02013;1.40, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.030) outcomes at discharge for women. At follow&#x02010;up, female sex was not a significant predictor for good outcome (OR&#x02009;=&#x02009;0.91, 95% CI: 0.78&#x02013;1.05, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.193) (Figure&#x000a0;<xref rid="ene70092-fig-0004" ref-type="fig">4</xref>).</p><fig position="float" fig-type="FIGURE" id="ene70092-fig-0004"><label>FIGURE 4</label><caption><p>Predictors of outcome at discharge and follow&#x02010;up in multivariable binary logistic regression analyses (<italic toggle="yes">matched cohort 1</italic>) and conditional logistic regression (<italic toggle="yes">cohort 2</italic>). (A) Predictors of good outcome at discharge and follow&#x02010;up. (B) Predictors of excellent outcome at discharge and follow&#x02010;up. (C) Predictors of mortality at discharge and follow&#x02010;up. IVT, intravenous thrombolysis; NIHSS, National Institutes of Health Stroke Scale; (p)mRS, (premorbid) modified Rankin Scale; sICH, symptomatic intracranial hemorrhage. #Time from symptom onset OR time of recognition of stroke until flow restoration [min]. *Significant.</p></caption><graphic xlink:href="ENE-32-e70092-g001" position="anchor" id="jats-graphic-7"/></fig></sec><sec id="ene70092-sec-0017"><label>3.3.2</label><title>
<styled-content style="fixed-case" toggle="no">PSM</styled-content> Cohort 2</title><p>The second PSM cohort included 8.690 patients (50% women) and was well&#x02010;balanced with no significant differences regarding baseline characteristics, stroke severity, and cardiovascular risk factors. Women had lower rates of large&#x02010;artery atherosclerosis (24.2% vs. 30.2%, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, SMD&#x02009;=&#x02009;0.110) but higher rates of cardioembolic stroke (48.9% vs. 46.1%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.001, SMD&#x02009;=&#x02009;0.110). IVT administration, EVT completion, and reperfusion rates were similar across sexes, but periprocedural complications were slightly higher in females compared to males (20.6% vs. 18.3%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.006, SMD&#x02009;=&#x02009;0.056). At discharge, the rates of substantial neurological improvement were similar between sexes (46.6% vs. 45.5%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.202). Good and excellent outcomes at discharge were higher in females compared to males (29.3% vs. 26.6%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.003. and 16.5% vs. 14.7%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.014, respectively). Conversely, at follow&#x02010;up, males showed a higher rate of good and excellent outcomes (31.4% vs. 29.4%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.031. and 21.7% vs. 20.0%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.042, respectively). Mortality rates were similar at discharge and follow&#x02010;up (17.0% vs. 16.9%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.930. and 25.9% vs. 26.5%, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.485. respectively) (Table&#x000a0;<xref rid="ene70092-supitem-0001" ref-type="supplementary-material">S3</xref> and Figure&#x000a0;<xref rid="ene70092-fig-0002" ref-type="fig">2C</xref>).</p><p>Univariate analysis revealed that female sex was not significantly associated with complications (OR&#x02009;=&#x02009;0.97, 95% CI 0.89&#x02013;1.05, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.430) and sICH (OR&#x02009;=&#x02009;1.10, 95% CI 0.94&#x02013;1.29, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.231). However, it was associated with lower odds of delirium during the hospital stay (OR&#x02009;=&#x02009;0.56, 95% CI 0.41&#x02013;0.76, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001). Female sex was significantly associated with higher odds of a good outcome (OR&#x02009;=&#x02009;1.16, 95% CI 1.05&#x02013;1.27, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.003) and an excellent outcome at discharge (OR&#x02009;=&#x02009;1.16, 95% CI 1.03&#x02013;1.30, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.014). Similarly, to descriptive analysis, at follow&#x02010;up, female sex was associated with lower odds of a good (OR&#x02009;=&#x02009;0.90, 95% CI 0.82&#x02013;0.99, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.029) and excellent outcome (OR&#x02009;=&#x02009;0.90, 95% CI 0.81&#x02013;1.00, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.042) (Table&#x000a0;<xref rid="ene70092-supitem-0001" ref-type="supplementary-material">S4</xref>).</p><p>Conditional logistic regression showed that female sex was associated with better outcomes at discharge (OR&#x02009;=&#x02009;1.34, 95% CI 1.17&#x02013;1.53, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001 for good outcome; OR&#x02009;=&#x02009;1.30, 95% CI 1.11&#x02013;1.52, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001 for excellent outcome), but not at follow&#x02010;up (OR&#x02009;=&#x02009;1.04, 95% CI 0.90&#x02013;1.19, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.629 for good outcome; OR&#x02009;=&#x02009;1.02, 95% CI 0.88&#x02013;1.18, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.822 for excellent outcome) (Figure&#x000a0;<xref rid="ene70092-fig-0004" ref-type="fig">4</xref>).</p></sec></sec></sec><sec sec-type="discussion" id="ene70092-sec-0018"><label>4</label><title>Discussion</title><p>In our large, observational real&#x02010;world multicenter study with 11.896 patients from the GSR&#x02010;ET, we identified notable results regarding sex&#x02010;related differences. The key findings are as follows:</p><p>Firstly, in the unmatched cohort, women performed worse in univariate analysis, with lower rates of good and excellent outcomes at both discharge and follow&#x02010;up. However, multivariable regression revealed that female sex was associated with higher odds of achieving good and excellent outcomes at discharge, though this advantage did not persist at the 90&#x02010;day follow&#x02010;up. The shift reflects adjustments for baseline disparities, such as age, pre&#x02010;stroke disability, stroke severity, and cardiovascular risk factors, which revealed a protective effect of female sex in short&#x02010;term recovery. In the unmatched cohort, women were older, had higher pre&#x02010;stroke disability, more hypertension, and AF, and were more likely to have cardioembolic strokes and anterior circulation LVO, while men were more likely to be smokers and had large&#x02010;artery atherosclerosis. These findings align with previous research [<xref rid="ene70092-bib-0015" ref-type="bibr">15</xref>, <xref rid="ene70092-bib-0033" ref-type="bibr">33</xref>, <xref rid="ene70092-bib-0034" ref-type="bibr">34</xref>, <xref rid="ene70092-bib-0035" ref-type="bibr">35</xref>, <xref rid="ene70092-bib-0036" ref-type="bibr">36</xref>, <xref rid="ene70092-bib-0037" ref-type="bibr">37</xref>, <xref rid="ene70092-bib-0038" ref-type="bibr">38</xref>, <xref rid="ene70092-bib-0039" ref-type="bibr">39</xref>]. A systematic review of global sex differences in stroke epidemiology conducted by Appelros et&#x000a0;al. found that while stroke incidence was 33% higher in men, women tended to have more severe strokes and higher case&#x02010;fatality rates. The prevalence of AF and hypertension was also higher among female stroke patients, potentially contributing to worse outcomes [<xref rid="ene70092-bib-0033" ref-type="bibr">33</xref>]. Mavridis et&#x000a0;al. [<xref rid="ene70092-bib-0036" ref-type="bibr">36</xref>] explored more severe strokes in female patients in a study on 2.245 patients aged &#x02265;&#x02009;80&#x02009;years. Reid et&#x000a0;al. [<xref rid="ene70092-bib-0015" ref-type="bibr">15</xref>] observed that men were more likely to present with posterior circulation stroke. Despite AF being more prevalent in women and typically associated with anterior circulation strokes, the significant differences persisted even after adjusting for AF, suggesting other underlying factors. Lutsep and Hill [<xref rid="ene70092-bib-0038" ref-type="bibr">38</xref>] examined sex&#x02010;related differences in outcomes following EVT in 305 patients using data from the MERCI and Multi MERCI trials. Here, women had higher rates of vertebrobasilar occlusions compared to men. Data from the International Stroke Trial (IST) analyzing 17.370 ischemic stroke patients showed that women faced higher mortality rates at both 14&#x02009;days and 6&#x02009;months post&#x02010;stroke, and they were more frequently dependent or required institutional care. This study concluded that gender was an independent predictor of death or dependency at 6&#x02009;months [<xref rid="ene70092-bib-0034" ref-type="bibr">34</xref>].</p><p>Women received IVT less frequently than men without differences regarding the time from symptom onset to hospital admission. This disparity persisted even after PSM, suggesting additional factors or decision&#x02010;making differences may contribute to the observed treatment gap. Furthermore, while rates of EVT were similar between sexes, women had slightly lower successful reperfusion rates, despite an equal number of EVT passages. Periprocedural complications did not differ. A systematic review by Strong et&#x000a0;al. analyzing data from 2008 to 2018 found that women were historically less likely to receive IVT, with 13% lower odds compared to men, though this disparity has lessened over time. Regional variations persisted, with women in the US and most European countries less likely to receive IVT, a trend that was not true in Asia and Germany [<xref rid="ene70092-bib-0013" ref-type="bibr">13</xref>]. European studies showed similar IVT workflow times for both sexes, while North American data indicated slight delays for women [<xref rid="ene70092-bib-0040" ref-type="bibr">40</xref>]. The MR CLEAN Registry study on 3.180 EVT&#x02010;patients noted that women had less atherosclerosis but more vessel tortuosity than men, with similar reperfusion rates. Despite these differences, only 34% of women achieved functional independence compared to 46% of men [<xref rid="ene70092-bib-0025" ref-type="bibr">25</xref>]. Mavridis et&#x000a0;al. [<xref rid="ene70092-bib-0036" ref-type="bibr">36</xref>] found fewer women received IVT; however, women benefited more from EVT, while men had better outcomes with IVT. A study by Peycheva et&#x000a0;al. [<xref rid="ene70092-bib-0037" ref-type="bibr">37</xref>] on 995 anterior circulation LVO patients found that prior vascular events worsened outcomes in both sexes, but men faced more in&#x02010;hospital strokes, hemorrhages, and higher mortality at discharge.</p><p>To address sex&#x02010;specific disparities, we conducted PSM analyses, balancing for age, pre&#x02010;stroke disability, stroke severity by NIHSS at admission, and cardiovascular risk factors between sexes. After matching, female sex was consistently associated with better functional outcomes at discharge compared to men in both univariate and multivariate analyses. This highlights the resilience of women in short&#x02010;term recovery, even when adjusted. However, this short&#x02010;term advantage also did not persist at the 90&#x02010;day follow&#x02010;up, where men showed higher rates of good and excellent outcomes. Mortality at discharge and follow&#x02010;up remained comparable between sexes. The persistence of cardioembolic strokes as a dominant etiology in women, even after PSM, is a significant finding. Cardioembolic strokes are associated with greater stroke severity and higher rates of recurrent embolic events, even with oral anticoagulation, which can adversely affect long&#x02010;term outcomes after EVT [<xref rid="ene70092-bib-0041" ref-type="bibr">41</xref>]. Notably, women had significantly more cardioembolic strokes despite being matched for age and cardiovascular risk factors, pointing to the possible role of additional biological or sex&#x02010;specific mechanisms, such as variations in clot composition, coagulation pathways, or vascular physiology [<xref rid="ene70092-bib-0042" ref-type="bibr">42</xref>, <xref rid="ene70092-bib-0043" ref-type="bibr">43</xref>]. Further research is needed to better understand these mechanisms and their impact on stroke outcomes. IVT and EVT rates, as well as successful reperfusion, were consistent between sexes, although women experienced more periprocedural complications.</p><p>Our findings are different from earlier studies suggesting that there are no sex&#x02010;related differences in EVT outcomes [<xref rid="ene70092-bib-0017" ref-type="bibr">17</xref>, <xref rid="ene70092-bib-0023" ref-type="bibr">23</xref>, <xref rid="ene70092-bib-0024" ref-type="bibr">24</xref>, <xref rid="ene70092-bib-0038" ref-type="bibr">38</xref>, <xref rid="ene70092-bib-0044" ref-type="bibr">44</xref>, <xref rid="ene70092-bib-0045" ref-type="bibr">45</xref>, <xref rid="ene70092-bib-0046" ref-type="bibr">46</xref>]. However, subsequent analyses, including a post hoc analysis from the MR CLEAN trial and studies by Madsen et&#x000a0;al., reported worse 90&#x02010;day outcomes for women, even after adjusting for age, stroke severity, and pre&#x02010;stroke functional status [<xref rid="ene70092-bib-0010" ref-type="bibr">10</xref>, <xref rid="ene70092-bib-0020" ref-type="bibr">20</xref>]. Wr&#x000f3;bel et&#x000a0;al. [<xref rid="ene70092-bib-0047" ref-type="bibr">47</xref>] found in a study on 794 patients (51.4% female) that despite smaller early infarct volumes and better cerebral hemodynamics, women had worse functional outcomes. For every 10&#x02009;mL increase in early infarct volume, females had significantly lower odds of achieving excellent outcomes and higher mortality rates compared to males. Ahnstedt et&#x000a0;al. [<xref rid="ene70092-bib-0039" ref-type="bibr">39</xref>] also highlighted significant sex differences in stroke outcomes and treatment responses, with women showing greater benefit from IVT, potentially due to biological differences in clot composition, but this benefit was not uniform across all racial groups. Both sexes benefited equally from EVT. A study by Peycheva et&#x000a0;al. [<xref rid="ene70092-bib-0037" ref-type="bibr">37</xref>] on 995 anterior circulation LVO patients found that prior vascular events worsened outcomes in both sexes, but men with prior vascular events had more recurrent in&#x02010;hospital strokes and ICH.</p><p>Our described disparity&#x02014;where female sex was associated with better outcomes at discharge, but not at follow&#x02010;up&#x02014;may be influenced by unmeasured factors such as disparities in post&#x02010;stroke care, post&#x02010;stroke complications, rehabilitation access, or socio&#x02010;economic influences. Importantly, female sex was consistently associated with better outcomes at discharge in both the unmatched and matched cohorts, underscoring the significance of short&#x02010;term recovery advantages in women after EVT compared to men. While our findings demonstrate this better short&#x02010;term recovery, the underlying reasons remain unclear. Neither baseline disparities nor measured clinical factors fully explain this observation, highlighting the need for further research into potential sex&#x02010;specific biological and/or hormonal determinants. A cross&#x02010;sectional study from the National Health and Nutrition Examination Survey (2013&#x02013;2018) involving 14.699 adults linked depression to cardiovascular disease (CVD) risks. It found that while women generally had a lower initial risk of cardiovascular disease, those with severe depressive symptoms faced a significantly increased risk compared to men. This highlights the crucial role of integrating mental health support into stroke and cardiovascular disease management, especially for women, to improve long&#x02010;term outcomes [<xref rid="ene70092-bib-0048" ref-type="bibr">48</xref>].</p><p>The limitations of our study include its observational design without a control group, which limits our ability to directly evaluate the effectiveness of EVT across sexes. Important predictors like infarct volume and collateral status were not included in our data and therefore in the PSM, potentially affecting outcome assessments. Additionally, the presence of missing values and potential selection bias, where EVT might be preferentially given to those expected to benefit most, could influence results. Socioeconomic factors (e.g., educational level, income) were not considered, which may play a critical role in post&#x02010;stroke recovery and could explain the loss of short&#x02010;term recovery advantages in women. Although our PSM accounted for many confounders, it did not fully explore more complex predictors such as sex&#x02010;related differences in post&#x02010;stroke depression and other complications. Furthermore, our study was conducted only in Germany, which means that the results may not be applicable to other countries.</p><p>In conclusion, our large&#x02010;scale study of 11.896 EVT&#x02010;treated patients demonstrates that the commonly reported worse outcomes in women cannot be fully explained by baseline differences such as age, pre&#x02010;stroke disability, or cardiovascular comorbidities. Conversely, women achieved better short&#x02010;term outcomes at discharge, suggesting greater biological resilience in women, even when chronologically older with more cardiovascular risk factors. However, this short&#x02010;term advantage was lost during follow&#x02010;up, likely due to unmeasured factors such as disparities in post&#x02010;stroke care, rehabilitation access, or socio&#x02010;economic influences. Our findings underscore the need for personalized medical strategies, further research into sex&#x02010;specific biological and hormonal factors in acute care, and tailored long&#x02010;term care strategies particularly suited to female patients to address potential socio&#x02010;economic challenges affecting women's recovery.</p></sec><sec id="ene70092-sec-0023"><title>Author Contributions</title><p>
<bold>Constanze Single:</bold> formal analysis, data curation, writing &#x02013; original draft, investigation, visualization, methodology. <bold>Annerose Mengel:</bold> writing &#x02013; review and editing, resources, conceptualization. <bold>Kornelia Laichinger:</bold> writing &#x02013; review and editing, resources. <bold>Jennifer Sartor&#x02010;Pfeiffer:</bold> resources, writing &#x02013; review and editing. <bold>Nadja Selo:</bold> resources, writing &#x02013; review and editing, data curation. <bold>Florian Hennersdorf:</bold> writing &#x02013; review and editing, resources, data curation. <bold>Benjamin Bender:</bold> writing &#x02013; review and editing, resources, data curation. <bold>Milani Deb&#x02010;Chatterji:</bold> writing &#x02013; review and editing, validation. <bold>G&#x000f6;tz Thomalla:</bold> writing &#x02013; review and editing. <bold>Joshua Mbroh:</bold> writing &#x02013; review and editing, data curation, resources. <bold>Sven Poli:</bold> writing &#x02013; review and editing, data curation. <bold>Ulf Ziemann:</bold> writing &#x02013; review and editing. <bold>Ulrike Ernemann:</bold> writing &#x02013; review and editing. <bold>Katharina Feil:</bold> supervision, project administration, conceptualization, writing &#x02013; original draft, investigation, validation, methodology, visualization.</p></sec><sec sec-type="COI-statement" id="ene70092-sec-0022"><title>Conflicts of Interest</title><p>Constanze Single, Kornelia Laichinger, Jennifer Sartor&#x02010;Pfeiffer, Nadja Selo, Florian Hennersdorf, Benjamin Bender, Joshua Mbroh, and Ulrike Ernemann are reporting no disclosures. Annerose Mengel received grants from the University of T&#x000fc;bingen (AKF) and speakers' honoraria/consulting fees from AMGEN, all not related to this work. Milani Deb&#x02010;Chatterji received research grants from the Werner Otto Stiftung and University Hospital Schleswig&#x02010;Holstein and speaker honoraria from Astra Zeneca (not related to this work). G&#x000f6;tz Thomalla reports honoraria as consultant or lecturer from Acandis, Alexion, Amarin, Bayer, Boehringer Ingelheim, BristolMyersSquibb/Pfizer, Stryker, and research grants from the European Union (Horizon 2020), German Research Foundation (DFG), and the German Innovation Fund. Sven Poli reports research support from BMS/Pfizer, Boehringer Ingelheim, Daiichi Sankyo, German Federal Joint Committee Innovation Fund, and German Federal Ministry of Education and Research, Helena Laboratories and Werfen as well as speakers' honoraria/consulting fees from Alexion, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb/Pfizer, Daiichi Sankyo, Portola, and Werfen (not related to this work). Ulf Ziemann received grants from the European Research Council (ERC), German Ministry of Education and Research (BMBF), German Research Foundation (DFG), Else&#x02010;Kr&#x000f6;ner Fresenius Foundation, and consulting fees from CorTec GmbH (not related to this work). Katharina Feil received grants from the University of T&#x000fc;bingen (AKF) and speakers' honoraria/consulting fees from AstraZeneca and BMS/Pfizer (not related to this work).</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="ene70092-supitem-0001" position="float" content-type="local-data"><caption><p>
Tables S1&#x02013;S4.
</p></caption><media xlink:href="ENE-32-e70092-s001.docx"/></supplementary-material></sec></body><back><ack id="ene70092-sec-0019"><title>Acknowledgements</title><p>We thank Ms. Lina Mar&#x000ed;a Serna Higuita for her statistical assistance. Open Access funding enabled and organized by Projekt DEAL.</p></ack><sec sec-type="data-availability" id="ene70092-sec-0021"><title>Data Availability Statement</title><p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></sec><ref-list content-type="cited-references" id="ene70092-bibl-0001"><title>References</title><ref id="ene70092-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="ene70092-cit-0001">
<string-name>
<given-names>S. L.</given-names>
<surname>Gall</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Donnan</surname>
</string-name>, <string-name>
<given-names>H. M.</given-names>
<surname>Dewey</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Sex Differences in Presentation, Severity, and Management of Stroke in a Population&#x02010;Based Study</article-title>,&#x0201d; <source>Neurology</source>
<volume>74</volume>, no. <issue>12</issue> (<year>2010</year>): <fpage>975</fpage>&#x02013;<lpage>981</lpage>.<pub-id pub-id-type="pmid">20181922</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="ene70092-cit-0002">
<string-name>
<given-names>K.</given-names>
<surname>Grimes</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Mehndiratta</surname>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Chaturvedi</surname>
</string-name>, &#x0201c;<article-title>The Impact of Sex on Stroke Care: From Epidemiology to Outcome</article-title>,&#x0201d; <source>Journal of Stroke and Cerebrovascular Diseases</source>
<volume>33</volume> (<year>2024</year>): <elocation-id>107675</elocation-id>.<pub-id pub-id-type="pmid">38467238</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="ene70092-cit-0003">
<string-name>
<given-names>M. J.</given-names>
<surname>Reeves</surname>
</string-name>, <string-name>
<given-names>C. D.</given-names>
<surname>Bushnell</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Howard</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Sex Differences in Stroke: Epidemiology, Clinical Presentation, Medical Care, and Outcomes</article-title>,&#x0201d; <source>Lancet Neurology</source>
<volume>7</volume>, no. <issue>10</issue> (<year>2008</year>): <fpage>915</fpage>&#x02013;<lpage>926</lpage>.<pub-id pub-id-type="pmid">18722812</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="ene70092-cit-0004">
<string-name>
<given-names>D.</given-names>
<surname>Renedo</surname>
</string-name>, <string-name>
<given-names>J. N.</given-names>
<surname>Acosta</surname>
</string-name>, <string-name>
<given-names>A. C.</given-names>
<surname>Leasure</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Burden of Ischemic and Hemorrhagic Stroke Across the US From 1990 to 2019</article-title>,&#x0201d; <source>JAMA Neurology</source>
<volume>81</volume> (<year>2024</year>): <fpage>394</fpage>&#x02013;<lpage>404</lpage>.<pub-id pub-id-type="pmid">38436973</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="ene70092-cit-0005">
<string-name>
<given-names>S. A. E.</given-names>
<surname>Peters</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Carcel</surname>
</string-name>, <string-name>
<given-names>E. R. C.</given-names>
<surname>Millett</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Woodward</surname>
</string-name>, &#x0201c;<article-title>Sex Differences in the Association Between Major Risk Factors and the Risk of Stroke in the UK Biobank Cohort Study</article-title>,&#x0201d; <source>Neurology</source>
<volume>95</volume>, no. <issue>20</issue> (<year>2020</year>): <fpage>e2715</fpage>&#x02013;<lpage>e2726</lpage>.<pub-id pub-id-type="pmid">33067404</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="ene70092-cit-0006">
<string-name>
<given-names>M. D.</given-names>
<surname>Howe</surname>
</string-name> and <string-name>
<given-names>L. D.</given-names>
<surname>McCullough</surname>
</string-name>, &#x0201c;<article-title>Prevention and Management of Stroke in Women</article-title>,&#x0201d; <source>Expert Review of Cardiovascular Therapy</source>
<volume>13</volume>, no. <issue>4</issue> (<year>2015</year>): <fpage>403</fpage>&#x02013;<lpage>415</lpage>.<pub-id pub-id-type="pmid">25747877</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="ene70092-cit-0007">
<string-name>
<given-names>N.</given-names>
<surname>The Lancet</surname>
</string-name>, &#x0201c;<article-title>Sex Differences and Stroke Prevention</article-title>,&#x0201d; <source>Lancet Neurology</source>
<volume>13</volume>, no. <issue>4</issue> (<year>2014</year>): <fpage>339</fpage>.<pub-id pub-id-type="pmid">24646867</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="ene70092-cit-0008">
<string-name>
<given-names>M. B.</given-names>
<surname>Tariq</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Ali</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Salazar&#x02010;Marioni</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Women With Large Vessel Occlusion Acute Ischemic Stroke Are Less Likely to be Routed to Comprehensive Stroke Centers</article-title>,&#x0201d; <source>Journal of the American Heart Association</source>
<volume>12</volume>, no. <issue>14</issue> (<year>2023</year>): <elocation-id>e029830</elocation-id>.<pub-id pub-id-type="pmid">37462071</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="ene70092-cit-0009">
<string-name>
<given-names>X.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Carcel</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Hsu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Differences in the Pre&#x02010;Hospital Management of Women and Men With Stroke by Emergency Medical Services in New South Wales</article-title>,&#x0201d; <source>Medical Journal of Australia</source>
<volume>217</volume>, no. <issue>3</issue> (<year>2022</year>): <fpage>143</fpage>&#x02013;<lpage>148</lpage>.<pub-id pub-id-type="pmid">35831059</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="ene70092-cit-0010">
<string-name>
<given-names>M.</given-names>
<surname>Goyal</surname>
</string-name>, <string-name>
<given-names>B. K.</given-names>
<surname>Menon</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>van Zwam</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Endovascular Thrombectomy After Large&#x02010;Vessel Ischaemic Stroke: A Meta&#x02010;Analysis of Individual Patient Data From Five Randomised Trials</article-title>,&#x0201d; <source>Lancet</source>
<volume>387</volume>, no. <issue>10029</issue> (<year>2016</year>): <fpage>1723</fpage>&#x02013;<lpage>1731</lpage>.<pub-id pub-id-type="pmid">26898852</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="ene70092-cit-0011">
<string-name>
<given-names>V.</given-names>
<surname>Puetz</surname>
</string-name>, <string-name>
<given-names>H. L.</given-names>
<surname>Lutsep</surname>
</string-name>, and <string-name>
<given-names>T. N.</given-names>
<surname>Nguyen</surname>
</string-name>, &#x0201c;<article-title>Endovascular Therapy for Basilar Artery Occlusion: Among the First to Conceptualize, Last to Prove</article-title>,&#x0201d; <source>Stroke</source>
<volume>54</volume>, no. <issue>3</issue> (<year>2023</year>): <fpage>905</fpage>&#x02013;<lpage>908</lpage>.<pub-id pub-id-type="pmid">36688315</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="ene70092-cit-0012">
<string-name>
<given-names>K.</given-names>
<surname>Feil</surname>
</string-name>, <string-name>
<given-names>M. T.</given-names>
<surname>Berndt</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Wunderlich</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Endovascular Thrombectomy for Basilar Artery Occlusion Stroke: Analysis of the German Stroke Registry&#x02010;Endovascular Treatment</article-title>,&#x0201d; <source>European Journal of Neurology</source>
<volume>30</volume>, no. <issue>5</issue> (<year>2023</year>): <fpage>1293</fpage>&#x02013;<lpage>1302</lpage>.<pub-id pub-id-type="pmid">36692229</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="ene70092-cit-0013">
<string-name>
<given-names>B.</given-names>
<surname>Strong</surname>
</string-name>, <string-name>
<given-names>L. D.</given-names>
<surname>Lisabeth</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Reeves</surname>
</string-name>, &#x0201c;<article-title>Sex Differences in IV Thrombolysis Treatment for Acute Ischemic Stroke: A Systematic Review and Meta&#x02010;Analysis</article-title>,&#x0201d; <source>Neurology</source>
<volume>95</volume>, no. <issue>1</issue> (<year>2020</year>): <fpage>e11</fpage>&#x02013;<lpage>e22</lpage>.<pub-id pub-id-type="pmid">32522796</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="ene70092-cit-0014">
<string-name>
<given-names>P.</given-names>
<surname>Wueger</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Noseda</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Pagnamenta</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Sex Differences in Functional Outcomes of Intravenous Thrombolysis Among Patients With Lacunar Stroke</article-title>,&#x0201d; <source>Frontiers in Neurology</source>
<volume>15</volume> (<year>2024</year>): <elocation-id>1341423</elocation-id>.<pub-id pub-id-type="pmid">38445264</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="ene70092-cit-0015">
<string-name>
<given-names>J. M.</given-names>
<surname>Reid</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Dai</surname>
</string-name>, <string-name>
<given-names>G. J.</given-names>
<surname>Gubitz</surname>
</string-name>, <string-name>
<given-names>M. K.</given-names>
<surname>Kapral</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Christian</surname>
</string-name>, and <string-name>
<given-names>S. J.</given-names>
<surname>Phillips</surname>
</string-name>, &#x0201c;<article-title>Gender Differences in Stroke Examined in a 10&#x02010;Year Cohort of Patients Admitted to a Canadian Teaching Hospital</article-title>,&#x0201d; <source>Stroke</source>
<volume>39</volume>, no. <issue>4</issue> (<year>2008</year>): <fpage>1090</fpage>&#x02013;<lpage>1095</lpage>.<pub-id pub-id-type="pmid">18292386</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="ene70092-cit-0016">
<string-name>
<given-names>L. D.</given-names>
<surname>Lisabeth</surname>
</string-name>, <string-name>
<given-names>D. L.</given-names>
<surname>Brown</surname>
</string-name>, <string-name>
<given-names>L. B.</given-names>
<surname>Morgenstern</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Factors Influencing Sex Differences in Poststroke Functional Outcome</article-title>,&#x0201d; <source>Stroke</source>
<volume>46</volume>, no. <issue>3</issue> (<year>2015</year>): <fpage>860</fpage>&#x02013;<lpage>863</lpage>, <ext-link xlink:href="https://www.ahajournals.org/doi/abs/10.1161/STROKEAHA.114.007985" ext-link-type="uri">https://www.ahajournals.org/doi/abs/10.1161/STROKEAHA.114.007985</ext-link>.<pub-id pub-id-type="pmid">25633999</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="ene70092-cit-0017">
<string-name>
<given-names>V.</given-names>
<surname>Chalos</surname>
</string-name>, <string-name>
<given-names>I. R.</given-names>
<surname>de Ridder</surname>
</string-name>, <string-name>
<given-names>H. F.</given-names>
<surname>Lingsma</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Does Sex Modify the Effect of Endovascular Treatment for Ischemic Stroke?</article-title>,&#x0201d; <source>Stroke</source>
<volume>50</volume>, no. <issue>9</issue> (<year>2019</year>): <fpage>2413</fpage>&#x02013;<lpage>2419</lpage>.<pub-id pub-id-type="pmid">31412753</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="ene70092-cit-0018">
<string-name>
<given-names>S. A.</given-names>
<surname>Sheth</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Lee</surname>
</string-name>, <string-name>
<given-names>S. J.</given-names>
<surname>Warach</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Sex Differences in Outcome After Endovascular Stroke Therapy for Acute Ischemic Stroke</article-title>,&#x0201d; <source>Stroke</source>
<volume>50</volume>, no. <issue>9</issue> (<year>2019</year>): <fpage>2420</fpage>&#x02013;<lpage>2427</lpage>.<pub-id pub-id-type="pmid">31412752</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="ene70092-cit-0019">
<string-name>
<given-names>I. R.</given-names>
<surname>de Ridder</surname>
</string-name>, <string-name>
<given-names>P. S. S.</given-names>
<surname>Fransen</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Beumer</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Is Intra&#x02010;Arterial Treatment for Acute Ischemic Stroke Less Effective in Women Than in Men?</article-title>,&#x0201d; <source>Interventional Neurology</source>
<volume>5</volume>, no. <issue>3&#x02013;4</issue> (<year>2016</year>): <fpage>174</fpage>&#x02013;<lpage>178</lpage>.<pub-id pub-id-type="pmid">27781046</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="ene70092-cit-0020">
<string-name>
<given-names>T. E.</given-names>
<surname>Madsen</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>DeCroce&#x02010;Movson</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Hemendinger</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Sex Differences in 90&#x02010;Day Outcomes After Mechanical Thrombectomy for Acute Ischemic Stroke</article-title>,&#x0201d; <source>Journal of NeuroInterventional Surgery</source>
<volume>11</volume>, no. <issue>3</issue> (<year>2019</year>): <fpage>221</fpage>&#x02013;<lpage>225</lpage>.<pub-id pub-id-type="pmid">30097482</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="ene70092-cit-0021">
<string-name>
<given-names>K.</given-names>
<surname>Uchida</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Yoshimura</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Sakai</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Yamagami</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Morimoto</surname>
</string-name>, and <collab collab-type="authors">RESCUE&#x02010;Japan Registry 2 Investigators</collab>
, &#x0201c;<article-title>Sex Differences in Management and Outcomes of Acute Ischemic Stroke With Large Vessel Occlusion</article-title>,&#x0201d; <source>Stroke</source>
<volume>50</volume>, no. <issue>7</issue> (<year>2019</year>): <fpage>1915</fpage>&#x02013;<lpage>1918</lpage>.<pub-id pub-id-type="pmid">31167622</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="ene70092-cit-0022">
<string-name>
<given-names>J. T.</given-names>
<surname>Fifi</surname>
</string-name>, <string-name>
<given-names>T. N.</given-names>
<surname>Nguyen</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Song</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Sex Differences in Endovascular Thrombectomy Outcomes in Large Vessel Occlusion: A Propensity&#x02010;Matched Analysis From the SELECT Study</article-title>,&#x0201d; <source>Journal of NeuroInterventional Surgery</source>
<volume>15</volume>, no. <issue>2</issue> (<year>2023</year>): <fpage>105</fpage>&#x02013;<lpage>112</lpage>.<pub-id pub-id-type="pmid">35232756</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="ene70092-cit-0023">
<string-name>
<given-names>A. A.</given-names>
<surname>Dmytriw</surname>
</string-name>, <string-name>
<given-names>J. C.</given-names>
<surname>Ku</surname>
</string-name>, <string-name>
<given-names>V. X. D.</given-names>
<surname>Yang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Do Outcomes Between Women and Men Differ After Endovascular Thrombectomy? A Meta&#x02010;Analysis</article-title>,&#x0201d; <source>AJNR. American Journal of Neuroradiology</source>
<volume>42</volume>, no. <issue>5</issue> (<year>2021</year>): <fpage>910</fpage>&#x02013;<lpage>915</lpage>.<pub-id pub-id-type="pmid">33664109</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="ene70092-cit-0024">
<string-name>
<given-names>M.</given-names>
<surname>Deb&#x02010;Chatterji</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Schlemm</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Flottmann</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Sex Differences in Outcome After Thrombectomy for Acute Ischemic Stroke Are Explained by Confounding Factors</article-title>,&#x0201d; <source>Clinical Neuroradiology</source>
<volume>31</volume>, no. <issue>4</issue> (<year>2021</year>): <fpage>1101</fpage>&#x02013;<lpage>1109</lpage>.<pub-id pub-id-type="pmid">33346850</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="ene70092-cit-0025">
<string-name>
<given-names>A.</given-names>
<surname>van der Meij</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Holswilder</surname>
</string-name>, <string-name>
<given-names>M. L. E.</given-names>
<surname>Bernsen</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Sex Differences in Clot, Vessel and Tissue Characteristics in Patients With a Large Vessel Occlusion Treated With Endovascular Thrombectomy</article-title>,&#x0201d; <source>European Stroke Journal</source>
<volume>9</volume> (<year>2024</year>): <fpage>600</fpage>&#x02013;<lpage>612</lpage>.<pub-id pub-id-type="pmid">38420950</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="ene70092-cit-0026">
<string-name>
<given-names>A. C.</given-names>
<surname>Alegiani</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Dorn</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Herzberg</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Systematic Evaluation of Stroke Thrombectomy in Clinical Practice: The German Stroke Registry Endovascular Treatment</article-title>,&#x0201d; <source>International Journal of Stroke</source>
<volume>14</volume>, no. <issue>4</issue> (<year>2019</year>): <fpage>372</fpage>&#x02013;<lpage>380</lpage>.<pub-id pub-id-type="pmid">30346260</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="ene70092-cit-0027">
<string-name>
<given-names>F. A.</given-names>
<surname>Wollenweber</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Tiedt</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Alegiani</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Functional Outcome Following Stroke Thrombectomy in Clinical Practice</article-title>,&#x0201d; <source>Stroke</source>
<volume>50</volume>, no. <issue>9</issue> (<year>2019</year>): <fpage>2500</fpage>&#x02013;<lpage>2506</lpage>.<pub-id pub-id-type="pmid">31337298</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="ene70092-cit-0028">
<string-name>
<given-names>A.</given-names>
<surname>Guenego</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Bourcier</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Guillen</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Neurological Improvement Predicts Clinical Outcome After Acute Basilar Artery Stroke Thrombectomy</article-title>,&#x0201d; <source>European Journal of Neurology</source>
<volume>28</volume>, no. <issue>1</issue> (<year>2021</year>): <fpage>117</fpage>&#x02013;<lpage>123</lpage>.<pub-id pub-id-type="pmid">32812674</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="ene70092-cit-0029">
<string-name>
<given-names>D. M.</given-names>
<surname>Kerr</surname>
</string-name>, <string-name>
<given-names>R. L.</given-names>
<surname>Fulton</surname>
</string-name>, and <string-name>
<given-names>K. R.</given-names>
<surname>Lees</surname>
</string-name>, &#x0201c;<article-title>Seven&#x02010;Day NIHSS Is a Sensitive Outcome Measure for Exploratory Clinical Trials in Acute Stroke: Evidence From the Virtual International Stroke Trials Archive</article-title>,&#x0201d; <source>Stroke</source>
<volume>43</volume>, no. <issue>5</issue> (<year>2012</year>): <fpage>1401</fpage>&#x02013;<lpage>1403</lpage>.<pub-id pub-id-type="pmid">22308254</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="ene70092-cit-0030">
<string-name>
<given-names>O. O.</given-names>
<surname>Zaidat</surname>
</string-name>, <string-name>
<given-names>A. J.</given-names>
<surname>Yoo</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Khatri</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke</article-title>,&#x0201d; <source>Stroke</source>
<volume>44</volume>, no. <issue>9</issue> (<year>2013</year>): <fpage>2650</fpage>&#x02013;<lpage>2663</lpage>.<pub-id pub-id-type="pmid">23920012</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="ene70092-cit-0031">
<string-name>
<given-names>G.</given-names>
<surname>Ford</surname>
</string-name> and <string-name>
<given-names>N.</given-names>
<surname>Freemantle</surname>
</string-name>, &#x0201c;<article-title>ECASS&#x02010;II: Intravenous Alteplase in Acute Ischaemic Stroke. European co&#x02010;Operative Acute Stroke Study&#x02010;II</article-title>,&#x0201d; <source>Lancet</source>
<volume>353</volume>, no. <issue>9146</issue> (<year>1999</year>): <fpage>65</fpage>.</mixed-citation></ref><ref id="ene70092-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="ene70092-cit-0032">
<string-name>
<given-names>F.</given-names>
<surname>de Los R&#x000ed;os la Rosa</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Khoury</surname>
</string-name>, <string-name>
<given-names>B. M.</given-names>
<surname>Kissela</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Eligibility for Intravenous Recombinant Tissue&#x02010;Type Plasminogen Activator Within a Population: The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial</article-title>,&#x0201d; <source>Stroke</source>
<volume>43</volume>, no. <issue>6</issue> (<year>2012</year>): <fpage>1591</fpage>&#x02013;<lpage>1595</lpage>.<pub-id pub-id-type="pmid">22442174</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="ene70092-cit-0033">
<string-name>
<given-names>P.</given-names>
<surname>Appelros</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Stegmayr</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Ter&#x000e9;nt</surname>
</string-name>, &#x0201c;<article-title>Sex Differences in Stroke Epidemiology: A Systematic Review</article-title>,&#x0201d; <source>Stroke</source>
<volume>40</volume>, no. <issue>4</issue> (<year>2009</year>): <fpage>1082</fpage>&#x02013;<lpage>1090</lpage>.<pub-id pub-id-type="pmid">19211488</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="ene70092-cit-0034">
<string-name>
<given-names>M.</given-names>
<surname>Niewada</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Kobayashi</surname>
</string-name>, <string-name>
<given-names>P. A.</given-names>
<surname>Sandercock</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Kami&#x00144;ski</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Cz&#x00142;onkowska</surname>
</string-name>, and <collab collab-type="authors">International Stroke Trial Collaborative Group</collab>
, &#x0201c;<article-title>Influence of Gender on Baseline Features and Clinical Outcomes Among 17,370 Patients With Confirmed Ischaemic Stroke in the International Stroke Trial</article-title>,&#x0201d; <source>Neuroepidemiology</source>
<volume>24</volume>, no. <issue>3</issue> (<year>2005</year>): <fpage>123</fpage>&#x02013;<lpage>128</lpage>.<pub-id pub-id-type="pmid">15637449</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="ene70092-cit-0035">
<string-name>
<given-names>J.</given-names>
<surname>Ospel</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Singh</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Ganesh</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Goyal</surname>
</string-name>, &#x0201c;<article-title>Sex and Gender Differences in Stroke and Their Practical Implications in Acute Care</article-title>,&#x0201d; <source>Journal of Stroke</source>
<volume>25</volume>, no. <issue>1</issue> (<year>2023</year>): <fpage>16</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">36746379</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="ene70092-cit-0036">
<string-name>
<given-names>A.</given-names>
<surname>Mavridis</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Reinholdsson</surname>
</string-name>, <string-name>
<given-names>K. S.</given-names>
<surname>Sunnerhagen</surname>
</string-name>, and <string-name>
<given-names>T.</given-names>
<surname>Abzhandadze</surname>
</string-name>, &#x0201c;<article-title>Predictors of Functional Outcome After Stroke: Sex Differences in Older Individuals</article-title>,&#x0201d; <source>Journal of the American Geriatrics Society</source>
<volume>72</volume> (<year>2024</year>): <fpage>2100</fpage>&#x02013;<lpage>2110</lpage>.<pub-id pub-id-type="pmid">38741476</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="ene70092-cit-0037">
<string-name>
<given-names>M.</given-names>
<surname>Peycheva</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Padlina</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Genceviciute</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Baseline Characteristics and Outcome of Stroke Patients After Endovascular Therapy According to Previous Symptomatic Vascular Disease and Sex</article-title>,&#x0201d; <source>Frontiers in Neurology</source>
<volume>15</volume> (<year>2024</year>): <elocation-id>1293905</elocation-id>.<pub-id pub-id-type="pmid">38694775</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="ene70092-cit-0038">
<string-name>
<given-names>H. L.</given-names>
<surname>Lutsep</surname>
</string-name> and <string-name>
<given-names>M. D.</given-names>
<surname>Hill</surname>
</string-name>, &#x0201c;<article-title>Effects of Sex on Mechanical Embolectomy Outcome</article-title>,&#x0201d; <source>Journal of Stroke and Cerebrovascular Diseases</source>
<volume>21</volume>, no. <issue>3</issue> (<year>2012</year>): <fpage>240</fpage>&#x02013;<lpage>242</lpage>.<pub-id pub-id-type="pmid">20851620</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="ene70092-cit-0039">
<string-name>
<given-names>H.</given-names>
<surname>Ahnstedt</surname>
</string-name>, <string-name>
<given-names>L. D.</given-names>
<surname>McCullough</surname>
</string-name>, and <string-name>
<given-names>M. J.</given-names>
<surname>Cipolla</surname>
</string-name>, &#x0201c;<article-title>The Importance of Considering Sex Differences in Translational Stroke Research</article-title>,&#x0201d; <source>Translational Stroke Research</source>
<volume>7</volume>, no. <issue>4</issue> (<year>2016</year>): <fpage>261</fpage>&#x02013;<lpage>273</lpage>.<pub-id pub-id-type="pmid">26830778</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="ene70092-cit-0040">
<string-name>
<given-names>C.</given-names>
<surname>Bushnell</surname>
</string-name>, <string-name>
<given-names>V. J.</given-names>
<surname>Howard</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Lisabeth</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Sex Differences in the Evaluation and Treatment of Acute Ischaemic Stroke</article-title>,&#x0201d; <source>Lancet Neurology</source>
<volume>17</volume>, no. <issue>7</issue> (<year>2018</year>): <fpage>641</fpage>&#x02013;<lpage>650</lpage>.<pub-id pub-id-type="pmid">29914709</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="ene70092-cit-0041">
<string-name>
<given-names>M. Y.</given-names>
<surname>Yu</surname>
</string-name>, <string-name>
<given-names>F. Z.</given-names>
<surname>Caprio</surname>
</string-name>, and <string-name>
<given-names>R. A.</given-names>
<surname>Bernstein</surname>
</string-name>, &#x0201c;<article-title>Cardioembolic Stroke</article-title>,&#x0201d; <source>Neurologic Clinics</source>
<volume>42</volume>, no. <issue>3</issue> (<year>2024</year>): <fpage>651</fpage>&#x02013;<lpage>661</lpage>.<pub-id pub-id-type="pmid">38937034</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="ene70092-cit-0042">
<string-name>
<given-names>B.</given-names>
<surname>Stamova</surname>
</string-name>, <string-name>
<given-names>G. C.</given-names>
<surname>Jickling</surname>
</string-name>, <string-name>
<given-names>B. P.</given-names>
<surname>Ander</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Gene Expression in Peripheral Immune Cells Following Cardioembolic Stroke Is Sexually Dimorphic</article-title>,&#x0201d; <source>PLoS One</source>
<volume>9</volume>, no. <issue>7</issue> (<year>2014</year>): <elocation-id>e102550</elocation-id>.<pub-id pub-id-type="pmid">25036109</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="ene70092-cit-0043">
<string-name>
<given-names>S.</given-names>
<surname>Fitzgerald</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Rossi</surname>
</string-name>, <string-name>
<given-names>O. M.</given-names>
<surname>Mereuta</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Per&#x02010;Pass Analysis of Acute Ischemic Stroke Clots: Impact of Stroke Etiology on Extracted Clot Area and Histological Composition</article-title>,&#x0201d; <source>Journal of NeuroInterventional Surgery</source>
<volume>13</volume>, no. <issue>12</issue> (<year>2021</year>): <fpage>1111</fpage>&#x02013;<lpage>1116</lpage>.<pub-id pub-id-type="pmid">33298510</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="ene70092-cit-0044">
<string-name>
<given-names>A.</given-names>
<surname>Carvalho</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Cunha</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Greg&#x000f3;rio</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Is the Efficacy of Endovascular Treatment for Acute Ischemic Stroke Sex&#x02010;Related</article-title>,&#x0201d; <source>Interventional Neurolog</source>
<volume>7</volume>, no. <issue>1&#x02013;2</issue> (<year>2018</year>): <fpage>42</fpage>&#x02013;<lpage>47</lpage>.</mixed-citation></ref><ref id="ene70092-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="ene70092-cit-0045">
<string-name>
<given-names>C.</given-names>
<surname>Ciardi</surname>
</string-name>, <string-name>
<given-names>J. J.</given-names>
<surname>Cirio</surname>
</string-name>, <string-name>
<given-names>E. V.</given-names>
<surname>Scrivano</surname>
</string-name>, <string-name>
<given-names>C. D.</given-names>
<surname>Bleise</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Lylyk</surname>
</string-name>, and <string-name>
<given-names>P.</given-names>
<surname>Lylyk</surname>
</string-name>, &#x0201c;<article-title>Sex&#x02010;Related Differences After Endovascular Treatment of Acute Ischemic Stroke in the &#x02018;Real World&#x02019;</article-title>,&#x0201d; <source>Journal of Stroke and Cerebrovascular Diseases</source>
<volume>29</volume>, no. <issue>11</issue> (<year>2020</year>): <elocation-id>105240</elocation-id>.<pub-id pub-id-type="pmid">33066881</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="ene70092-cit-0046">
<string-name>
<given-names>C.</given-names>
<surname>Lagebrant</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Ramgren</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Hassani Espili</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Mara&#x000f1;on</surname>
</string-name>, and <string-name>
<given-names>C.</given-names>
<surname>Kremer</surname>
</string-name>, &#x0201c;<article-title>Sex Differences in Collateral Circulation and Outcome After Mechanical Thrombectomy in Acute Ischemic Stroke</article-title>,&#x0201d; <source>Frontiers in Neurology</source>
<volume>13</volume> (<year>2022</year>): <elocation-id>878759</elocation-id>.<pub-id pub-id-type="pmid">35665053</pub-id>
</mixed-citation></ref><ref id="ene70092-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="ene70092-cit-0047">
<string-name>
<given-names>D.</given-names>
<surname>Wr&#x000f3;bel</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Wrona</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Homa</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Sex Alters the Effect of Perfusion Deficits on Functional Outcome in Patients With Acute Ischemic Stroke Undergoing Mechanical Thrombectomy</article-title>,&#x0201d; <source>Cerebrovascular Diseases</source> (<year>2024</year>): <fpage>1</fpage>&#x02013;<lpage>10</lpage>, <pub-id pub-id-type="doi">10.1159/000538633</pub-id>.</mixed-citation></ref><ref id="ene70092-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="ene70092-cit-0048">
<string-name>
<given-names>B.</given-names>
<surname>Thakur</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Strenth</surname>
</string-name>, <string-name>
<given-names>E. M.</given-names>
<surname>Arnold</surname>
</string-name>, and <string-name>
<given-names>F. D.</given-names>
<surname>Schneider</surname>
</string-name>, &#x0201c;<article-title>Sex Differences in the Association of Depression Symptoms and Cardiovascular Disease in Adults in the United States</article-title>,&#x0201d; <source>American Journal of Health Promotion</source>
<volume>38</volume> (<year>2024</year>): <fpage>1199</fpage>&#x02013;<lpage>1209</lpage>.<pub-id pub-id-type="pmid">38864762</pub-id>
</mixed-citation></ref></ref-list></back></article>